Health Care Equipment

NanoVibronix

NanoVibronix released FY2025 Q3 earnings on November 14 (EST), actual revenue USD 722K, actual EPS USD -0.9086

NanoVibronix released FY2025 9 Months Earnings on November 14 EST, with actual revenue of USD 2.241 M and actual EPS of USD -41.7871

NanoVibronix released FY2025 Semi-Annual Earnings on August 19 (EST), actual revenue USD 1.519 M, actual EPS USD -8.8379

NanoVibronix released FY2025 Q2 earnings on August 19 (EST), actual revenue USD 494K, actual EPS USD -1.0318

NanoVibronix Inc Reaches Agreement with New York Medical Center

NanoVibronix ENvue Medical Department Obtains Patent for Electromagnetic Navigation Technology

NanoVibronix Inc. Obtains US Patent for Pediatric Feeding Tube Guidance System

NanoVibronix clarifies false stock issuance information

NanoVibronix released FY2025 Q1 earnings on May 20, 2025 (EST) with actual revenue of USD 1.025 M and EPS of USD -39.8466

NanoVibronix Inc. Launches $10 Million Public Offering

NanoVibronix Inc. Delays Submission of Q1 2025 Financial Report

NanoVibronix's UroShield System Significantly Reduces Infections

NanoVibronix Inc Regains Compliance with Nasdaq

NanoVibronix released FY2024 Q4 earnings on March 31 (EST), actual revenue USD 444K, actual EPS USD -4.2146

NanoVibronix released FY2024 Annual Earnings on March 31 (EST), actual revenue USD 2.558 M, actual EPS USD -137.2984

NanoVibronix released FY2024 9 Months Earnings on November 14, 2024 (EST) with actual revenue of USD 2.114M and EPS of USD -90.1517

NanoVibronix released FY2024 Q3 earnings on November 14 (EST), actual revenue USD 376 K, actual EPS USD -3.5602

NanoVibronix released FY2024 Q2 earnings on August 14 (EST) with actual revenue of 817 K USD and EPS of -2.718 USD

NanoVibronix released FY2024 Semi-Annual earnings on August 14 (EST), actual revenue USD 1.738M, actual EPS USD -53.0032

Nanovibronix Launches UROSHIELD Clinical Study at the University of Michigan

Black Titan

SMX Security Matters

AXIL Brands

Petmed Express

Agape ATP

Diamond Hill Investment

Reto Eco-Solutions

Leverage Shares 2X Long GEMI Daily ETF

Destination XL

Mawson Infrastructure

Delcath

Electromed

Abbott Laboratories

Intuitive Surgical

Boston Scientific

Stryker

IDEXX Labs

Edwards Lifesciences

Resmed

DexCom

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap